A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy Subjects

NCT06858657 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HSK44459
DRUG: placebo

Sponsor

Haisco Pharmaceutical Group Co., Ltd.